Clinical trial
Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery
NCT00388011 · Javelin Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00388011 |
|---|---|
| Title | Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery |
| Official title | Randomized, Double-Blind, Placebo and Comparator-Controlled, Dose-Response Trial of the Efficacy and Safety of Intranasal Morphine, Intravenous Morphine and Placebo in Patients With Moderate to Severe Pain Following Orthopedic Surgery |
| Lead sponsor | Javelin Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hallux Valgus |
| Intervention type | Drug |
| Interventions | Intranasal Morphine (MNS075) 3.75 mg, Intravenous Morphine 7.5 mg, Intranasal morphine (MNS075) 7.5 mg, Intranasal morphine (MNS075) 15 mg, Intranasal morphine (MNS075) 30 mg, Intranasal placebo |
| Enrollment | 187 |
| Start date | Jan 1, 2005 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Oct 13, 2006 |
| Last update posted | Jan 14, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: